AOB: Summary for AMERICAN ORIENTL BIO - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 9:09pm SGT - The Singapore stock market is closed.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

American Oriental Bioengineering Inc. (AOB)

At 5:01AM SGT: 4.13 USD 0.00 (0.00%)

MORE ON AOB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AMERICAN ORIENTL BIO (NYSE:AOB) Delayed quote data

Last Trade:	4.13 USD
Trade Time:	5:01AM SGT
Change:	0.00 (0.00%)
Prev Close:	4.13
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	5.67

Day's Range:	N/A - N/A
52wk Range:	3.29 - 6.38
Volume:	0
Avg Vol (3m):	1,007,690
Market Cap:	323.47M
P/E (ttm):	8.36
EPS (ttm):	0.49
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Use Y! Toolbar to track stocks

Add AOB to Portfolio

Download Data

HEADLINES

•	5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
	at Motley Fool (Tue 10:44pm)

•	AMERICAN ORIENTAL BIOENGINEERING INC Financials
	EDGAR Online Financials (Sun, Feb 7)

•	5-Star Stocks Poised to Pop: Res-Care
	at Motley Fool (Sat, Jan 30)

•	The Next Great Place to Invest
	at Motley Fool (Fri, Jan 29)

•	American Oriental Bioengineering - A Value Investment
	at Seeking Alpha (Fri, Jan 29)

•	Five Potential '10-Baggers' for Under $10
	RealMoney by TheStreet.com (Thu, Jan 28)

•	China Aoxing Pharmaceutical Company Announces Successful Completion of Phase III Registration Clinical Study of Tilidine for Moderate to Severe Pain
	Marketwire (Mon, Jan 25)

•	9 Value Stocks Worth Considering Now
	at Seeking Alpha (Fri, Jan 22)

•	China Aoxing Pharmaceutical Company Announces Appointment of New Chief Financial Officer
	Marketwire (Wed, Jan 20)

•	These 5 Underdogs Are No Dogs
	at Motley Fool (Thu, Jan 14)

•	4-Star Stocks Poised to Pop: Universal Travel
	at Motley Fool (Wed, Jan 13)

•	5-Star Stocks on the Upswing
	at Motley Fool (Wed, Jan 13)

More Headlines for AOB...

ANALYST

EPS Est (next year) (Dec-09) :	0.58
EPS Est (in 2 years) (Dec-10) :	0.62
Avg Rec (current)*:	2.0
PEG Ratio:	1.13

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

American Oriental Bioengineering, Inc., along with its subsidiaries, engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products.

Full Company Profile

Add to Portfolio

Email to a Friend

•